Trilogy Capital Inc. Perkinelmer Inc Transaction History

Trilogy Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$134.91 - $172.49 $195,889 - $250,455	-1,452 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$127.81 - $155.84 $185,580 - $226,279	1,452 New	1,452 $224,000
Q1 2021 Apr 12, 2021	SELL	$120.35 - $160.53 $174,748 - $233,089	-1,452 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$122.05 - $147.91 $177,216 - $214,765	1,452 New	1,452 $208,000

575

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.